Atlas Trials

Treatment of Hepatitis C Virus Infection With Generic Sofosbuvir/Ledipasvir in Iranian Patients

Clinical trial NCT03061032 · UNKNOWN

Trial details

NCT number
NCT03061032
Sponsor
Iran Hepatitis Network
Status
UNKNOWN
Phase
Phase 3
Study type
INTERVENTIONAL
Hepatitis C
Start date
2017-03-01
Primary completion
2018-12-01
Enrollment
200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.